<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04229550</url>
  </required_header>
  <id_info>
    <org_study_id>H-15019685</org_study_id>
    <nct_id>NCT04229550</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of One-weak Heavy Drinking</brief_title>
  <acronym>ROSMET</acronym>
  <official_title>Metabolic Effects of One-Week Heavy Drinking and Fast Food Intake During Roskilde Festival in Young Healthy Male Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examination of the effect of one week's unhealthy lifestyle on glucose metabolism and liver
      parameters in a group of young, healthy males participating in Roskilde Festival 2016.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Metabolic effects of intermittent unhealthy lifestyle in otherwise young healthy adults are
      poorly studied. The investigators evaluated the effect of one week's unhealthy lifestyle on
      glucose metabolism and liver parameters in a group of young, healthy males participating in
      Roskilde Festival 2016.

      Festival participants were studied before and after participation (one week) in Roskilde
      Festival 2016 and matched with controls who lead a normal life for an equivalent period of
      time. An oral glucose tolerance test (OGTT), abdominal ultrasound and strain elastography for
      liver stiffness were performed together with a bioimpedance scan and cognitive tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">July 4, 2016</completion_date>
  <primary_completion_date type="Actual">July 4, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Impairment of glucose tolerance</measure>
    <time_frame>First day after intervention week</time_frame>
    <description>Evaluated by OGTT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hepatic steatosis</measure>
    <time_frame>First day after intervention week</time_frame>
    <description>Evaluated by abdominal ultrasound scan</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Altered cognitive function</measure>
    <time_frame>First day after intervention week</time_frame>
    <description>Evaluated by validated cognitive test (&quot;SCIP&quot;)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Metabolic Disturbance</condition>
  <condition>Alcohol; Harmful Use</condition>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>1 week of normal daily life and only by the National Health Board recommendated alcohol consumption.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Festival subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 week's participation in Roskilde Festival 2016</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Festival participation</intervention_name>
    <description>One week's participation in Roskilde Festival 2016 or living a normal daily life.</description>
    <arm_group_label>Festival subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI of 18,5-25 kg/m2

          -  Normal liver function (assessed by ASAT, ALAT, GGT, alkaline phosphatase, albumin and
             bilirubin, coagulation factors II, VII and X, INR and platelets)

        Exclusion Criteria:

          -  Planning alcohol withdrawal or dieting/a special low-fat diet during Roskilde Festival

          -  Diabetes or pre-diabetes

          -  First degree relatives with diabetes

          -  Kidney disease (eGFT&lt;60 ml/min and/or albuminuria)

          -  Chronic diseases (in addition to those already mentioned) that could affect
             participation in festival activities (concerts and parties)

          -  Any condition in which the investigator believed would make it impossible to
             participate
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filip K Knop, Prof,MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>January 12, 2020</last_update_submitted>
  <last_update_submitted_qc>January 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>Filip Krag Knop</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

